Bridgeway Capital Management, LLC Electro Core, Inc. Transaction History

Bridgeway Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.61 $4,050 - $9,150	-15,000 Reduced 16.04%	78,500 $40,000
Q4 2021 Feb 14, 2022	SELL	$0.58 - $1.09 $28,999 - $54,500	-50,000 Reduced 34.84%	93,500 $54,000
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.18 $120,900 - $153,400	-130,000 Reduced 47.53%	143,500 $162,000
Q2 2021 Aug 16, 2021	SELL	$1.19 - $2.06 $29,750 - $51,500	-25,000 Reduced 8.38%	273,500 $325,000
Q1 2021 May 17, 2021	BUY	$1.62 - $3.05 $232,470 - $437,675	143,500 Added 92.58%	298,500 $615,000

Q4 2020 Feb 16, 2021	BUY	$1.44 - $1.98 $223,200 - $306,900	155,000 New	155,000 $242,000
Q1 2020 May 15, 2020	SELL	$0.33 - $1.62 $36,696 - $180,144	-111,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.25 - $5.0 $36,500 - $146,000	29,200 Added 35.61%	111,200 $244,000
Q2 2019 Aug 14, 2019	SELL	$1.65 - $6.72 $41,250 - $168,000	-25,000 Reduced 23.36%	82,000 $164,000
Q1 2019 May 15, 2019	BUY	$4.84 - $9.07 $517,880 - $970,490	107,000 New	107,000 $749,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $455M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.